Search by Drug Name or NDC
NDC 16729-0292-12 Dalfampridine 10 mg/1 Details
Dalfampridine 10 mg/1
Dalfampridine is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Accord Healthcare Inc.. The primary component is DALFAMPRIDINE.
MedlinePlus Drug Summary
Dalfampridine is used to improve walking in people who have multiple sclerosis (MS; a disease in which the nerves do not function properly and may cause weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control). Dalfampridine may be used alone or with other medications that control the symptoms of MS. Dalfampridine is in a class of medications called potassium channel blockers. It works by strengthening the signals sent by the brain through nerves that have been damaged by MS.
Related Packages: 16729-0292-12Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dalfampridine
Product Information
| NDC | 16729-0292 |
|---|---|
| Product ID | 16729-292_0e1eac87-c9fb-4d7f-e063-6394a90a3070 |
| Associated GPIs | 62406030007420 |
| GCN Sequence Number | 066066 |
| GCN Sequence Number Description | dalfampridine TAB ER 12H 10 MG ORAL |
| HIC3 | H0F |
| HIC3 Description | AGTS TX NEUROMUSC TRANSMISSION DIS,POT-CHAN BLKR |
| GCN | 28246 |
| HICL Sequence Number | 013907 |
| HICL Sequence Number Description | DALFAMPRIDINE |
| Brand/Generic | Generic |
| Proprietary Name | Dalfampridine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dalfampridine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/1 |
| Substance Name | DALFAMPRIDINE |
| Labeler Name | Accord Healthcare Inc. |
| Pharmaceutical Class | Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206863 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 16729-0292-12 (16729029212)
| NDC Package Code | 16729-292-12 |
|---|---|
| Billing NDC | 16729029212 |
| Package | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16729-292-12) |
| Marketing Start Date | 2018-09-18 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.53381 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | DALFAMPRIDINE ER 10 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis